Home › Funds › WELLINGTON MANAGEMENT GROUP LLP › ABBV

WELLINGTON MANAGEMENT GROUP LLP position in ABBV

ABBVIE INC · Health Care

WELLINGTON MANAGEMENT GROUP LLP reported holding 10,705,904 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$2.80B, representing 0.55% of its reported portfolio and ranking #31 among its reported holdings. WELLINGTON MANAGEMENT GROUP LLP has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)10.71M sh
Reported value held$2.80B
Portfolio Weight0.55%
First reportedQ3 2023
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How WELLINGTON MANAGEMENT GROUP LLP's ABBV position evolved

WELLINGTON MANAGEMENT GROUP LLP first disclosed a stake in ABBV in Q3 2023 at 417,644 shares (US$62.3M). The position peaked in Q4 2025 at 14,926,683 shares, worth US$3.41B. Across 13 filings, WELLINGTON MANAGEMENT GROUP LLP increased the stake 8 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 10,705,904 shares valued at US$2.80B — an increase of 5,650,315 shares quarter over quarter.. Notable position changes include a 129% increase in Q4 2023 (shares rose 19% over the following quarter), a 198% increase in Q1 2024 (shares fell 5% over the following quarter), a 457% increase in Q3 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 417.64K $62.25M New
Q4 2023 954.37K $147.90M Add
Q1 2024 2.85M $518.09M Add
Q2 2024 2.88M $494.42M Add
Q3 2024 1.57M $309.48M Reduce
Q4 2024 2.24M $397.45M Add
Q1 2025 1.81M $379.73M Reduce
Q2 2025 1.89M $350.91M Add
Q3 2025 10.54M $2.44B Add
Q4 2025 14.93M $3.41B Add
Q1 2026 6.90M $1.50B Reduce
Q2 2026 5.06M $1.27B Reduce
Q3 2026 10.71M $2.80B Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$38.97B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has WELLINGTON MANAGEMENT GROUP LLP held ABBV?

WELLINGTON MANAGEMENT GROUP LLP has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is WELLINGTON MANAGEMENT GROUP LLP's current position in ABBV?

As of Q3 2026, WELLINGTON MANAGEMENT GROUP LLP holds 10.71M shares of ABBV (ABBVIE INC), valued at $2.80B, representing 0.55% of its reported portfolio and ranking #31.

Has WELLINGTON MANAGEMENT GROUP LLP been buying or selling ABBV?

In the latest 13F filing (Q3 2026), WELLINGTON MANAGEMENT GROUP LLP increased its position in ABBV. The position peaked in Q4 2025 at 14.93M shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.